Prostate cancer affects 1 of every 6 men in the United States
Traditional, linear regimen of prostate cancer treatment may need to be reexamined as oncologists learn new ways to incorporate new therapies
Initial clinical findings indicate that results with radiotherapies sometime improve when combined with immunotherapy
Immunotherapies again made headlines in oncology last month
Radiation therapy (RT) used in combination with hormonal approaches continues to be a viable strategy for treating localized high-risk prostate cancer patients
Screening for prostate cancer does work, despite controversy about its efficacy, according to IPCC Co-chair Leonard G. Gomella
Hormonal therapies have long been the standard of care for metastatic advanced prostate cancer
As research into novel vaccine approaches for treating advanced prostate cancer continues...
Increased prostate cancer screening has led to overtreatment and has not significantly reduced mortality rates in prostate cancer